According to a report by Reuters on April 8, U.S. President Donald Trump said that the United States would soon announce tariffs on pharmaceutical imports.
Trump made this statement at an event hosted by the National Republican Congressional Committee (NRCC). Trump said that the prices paid by the United States for medicines are often several times higher than those of the countries actually producing the drugs, because the U.S. does not produce its own drugs. He also believed that once tariffs are imposed on medicines, pharmaceutical companies will choose to open factories in the U.S., as it is "the largest market".
When Trump announced last week that the U.S. would impose broad "reciprocal tariffs" on imported products from overseas, the scope did not yet cover pharmaceutical products.
According to another report by Reuters on the local time of April 8, the European pharmaceutical industry trade lobbying organization EFPIA (which includes major European pharmaceutical giants such as Bayer, Novartis, and Novo Nordisk as supporters) issued a warning at a meeting that the U.S. was likely to include medicines within the range of tariff collection. EFPIA stated that it has urged EU Commission President Ursula von der Leyen to take "swift and thorough action" to reduce the risk of related industries flowing out to the U.S.
This article is an exclusive contribution from Guancha.cn and cannot be reprinted without permission.
Original source: https://www.toutiao.com/article/7491127988965081600/
Disclaimer: The views expressed in this article are solely those of the author. Please use the "thumbs up/thumbs down" buttons below to express your opinion.